Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation.
Doo Soo JeonHyungseok KangYong Soo KwonJae-Joon YimTae Sun ShimPublished in: Journal of Korean medical science (2020)
mDST coverage is gradually increasing and contributes to reducing the time to MDR-TB treatment initiation. Further efforts are needed to achieve universal access to mDST and to properly integrate mDST into routine clinical practice.